Investors 2018-11-28T10:36:21+00:00


Medibio Limited is an evidence-based medical technology company that is developing the world’s first objective diagnostic system for mental health illnesses. Medibio Limited is listed on the Australian Stock Exchange (ASX: MEB) and also trades on the OTCQB Venture Market (OTCQB: MDBIF).

Medibio Highlights

  • Game Changing Technology
  • Multiple Applications and Use Cases
  • Large, Underserved, Growing Market
  • Positive Global Financial Benefit
  • Superior Value Proposition
  • Patent Protected Technology
  • Regulatory Approvals on Track

Shareholder Services

Investors may find additional information on Medibio stock, including real-time quotes, announcements, filings, and history, at the Australian Stock Exchange ( and OTC Markets ( The Medibio share registry is maintained by Computershare, where shareholders can access information about shareholding.


U.S. Media Enquiries:

Brian Mower: Chief Financial Officer
T: +1 (952) 222 3126

Australian Media Enquiries:

NWR Communications:
T: +61 (0) 412 036 231

Latest Investor Deck


All Investor Inquiries

Contact Us